Literature DB >> 29247436

Capsule Commentary on Belson et al., Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.

Mary A Andrews1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29247436      PMCID： PMC5834968          DOI： 10.1007/s11606-017-4251-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

2.  Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.

Authors:  Virginie Beslon; Perrine Moreau; Annabel Maruani; Hubert Maisonneuve; Bruno Giraudeau; Jean-Pascal Fournier
Journal:  J Gen Intern Med       Date:  2017-12-04       Impact factor: 5.128

3.  Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.

Authors:  Lisa K Stamp; William J Taylor; Peter B Jones; Jo L Dockerty; Jill Drake; Christopher Frampton; Nicola Dalbeth
Journal:  Arthritis Rheum       Date:  2012-08

4.  The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.

Authors:  Khaled M Talaat; Amira R el-Sheikh
Journal:  Am J Nephrol       Date:  2007-07-04       Impact factor: 3.754
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.